New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.

Good day, and welcome to the IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025. The next presenting company is Flux Power Holdings Inc. [Operator Instructions] I'd now like to turn ...

Still, riders worry adding new stations will strain a system they see as already struggling. More Money for Harrell's ...

It’s happening now the thing we’ve waited for, a game-changer that hits like the last piece snapping into place across the EV ...

With FDA approval to treat marginal zone lymphoma (MZL), Bristol Myers Squibb’s Breyanzi has become the first CAR-T therapy ...

BioNTech SE ( ($BNTX) ) has issued an announcement. On December 9, 2025, BioNTech SE and Bristol Myers Squibb announced interim results from a ...

It’s not the first time OPM has attempted to merge disparate HR IT systems across government, but the agency said the current ...

The U.S. Food and Drug Administration (FDA) has approved Breyanzi (lisocabtagene maraleucel) for the treatment of adults with relapsed or refractory marginal zone lymphoma who have received at least ...

ORLANDO, Fla. — Rusfertide, a weekly self-injected peptide, maintained control of hematocrit levels and reductions in ...

What are Valorant ranks? We've taken a deep dive into the Valorant ranking system to show you how it works and what the current distribution is. Looking at these figures, we can glean all kinds of ...

EMMI leverages “the largest global database of binding data” to generate small molecule drugs in new chemical space to tackle hard targets.

The General Motors 5.7 LS1 engine was a naturally aspirated small-block V8 engine with two valves per cylinder and the ...